Oppenheimer & Co. Inc. Has $6.26 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Oppenheimer & Co. Inc. grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 32.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 47,361 shares of the financial services provider’s stock after purchasing an additional 11,698 shares during the quarter. Oppenheimer & Co. Inc. owned about 0.10% of iShares Biotechnology ETF worth $6,262,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the third quarter worth approximately $29,000. HHM Wealth Advisors LLC grew its position in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $32,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF during the third quarter worth approximately $36,000. Finally, Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $137.03 on Friday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business’s 50 day simple moving average is $135.82 and its 200 day simple moving average is $140.68.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.